Nordwand Advisors, LLC Pro Phase Labs, Inc. Transaction History
Nordwand Advisors, LLC
- $266 Billion
- Q1 2025
A detailed history of Nordwand Advisors, LLC transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Nordwand Advisors, LLC holds 10,000 shares of PRPH stock, worth $3,100. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$3,100% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRPH
# of Institutions
34Shares Held
2.42MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA408KShares$126,5620.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny286KShares$88,8100.0% of portfolio
-
Citizens Financial Group Inc270KShares$83,8240.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL229KShares$71,1300.0% of portfolio
-
Geode Capital Management, LLC Boston, MA228KShares$70,5850.0% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $4.97M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...